Kymera Therapeutics, Inc. (KYMR)
79.21
-1.44
(-1.79%)
USD |
NASDAQ |
May 21, 09:42
Kymera Therapeutics Total Liabilities (Quarterly) : 129.38M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 32.85B |
| Revolution Medicines, Inc. | 753.82M |
| Catalyst Pharmaceuticals, Inc. | 134.91M |
| Regeneron Pharmaceuticals, Inc. | 9.445B |
| AbbVie, Inc. | 143.08B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.669B |
| Shareholders Equity (Quarterly) | 1.540B |
| Debt to Equity Ratio | 0.0523 |
| Current Ratio | 10.81 |
| Net Debt Paydown Yield | 0.02% |